Lucas develops a system that utilizes imaging analysis techniques to detect, measure, categorize, and track lung nodules in screening CT images. This technology enhances early diagnosis and monitoring of lung conditions, leading to improved patient outcomes through precise nodule management.
Funding
$5.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The early detection and monitoring of lung nodules, indicative of conditions like lung cancer, often rely on manual analysis of screening CT images, which can be time-consuming, prone to human error, and may lead to delayed or inaccurate diagnoses. This can result in suboptimal patient outcomes and increased healthcare costs.
Solution
Monitor Corporation provides MONCAD, a medical AI solution designed to enhance the accuracy and efficiency of lung nodule detection, measurement, categorization, and tracking in CT images. MONCAD serves as a smart diagnostic AI partner, offering a second opinion to radiologists and accelerating the diagnostic process. The continuously improving and expanding solution utilizes various modalities to provide a comprehensive analysis of lung nodules, aiding in the early diagnosis and monitoring of lung conditions.
Target Audience
The primary target audience includes radiologists, pulmonologists, and other healthcare professionals involved in lung cancer screening and diagnosis, as well as hospitals and imaging centers.
Features
- AI-powered detection of lung nodules in CT images.
- Automated measurement and categorization of detected nodules.
- Longitudinal tracking of nodule changes over time.
- Integration with existing medical imaging workflows.
- Provides a second opinion to radiologists, improving diagnostic accuracy.